Analysis of HIV-1 drug resistant mutations by line probe assay and direct sequencing in a cohort of therapy naive HIV-1 infected Italian patients

BMC Microbiology

Volumn 1, Issue , 2001, Pages 1-6

  Re, Maria Carla ^a   Monari, Paola ^a   Bon, Isabella ^a   Gibellini, Davide ^a   Vitone, Francesca ^a   Borderi, Marco ^a   La Placa, Michele ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; PROTEINASE INHIBITOR; RNA DIRECTED DNA POLYMERASE; RNA DIRECTED DNA POLYMERASE INHIBITOR;

ADULT; AMINO ACID SUBSTITUTION; ARTICLE; ASSAY; BLOOD ANALYSIS; BLOOD SAMPLING; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; GENE PROBE; GENE SEQUENCE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LINE PROBE ASSAY; MALE; NONHUMAN; SEQUENCE ANALYSIS; STATISTICAL SIGNIFICANCE; VIRUS GENE; VIRUS MUTATION; VIRUS RESISTANCE; ANTIBIOTIC RESISTANCE; DRUG EFFECT; GENETICS; ITALY; MICROBIOLOGICAL EXAMINATION; MOLECULAR GENETICS; PHYSIOLOGY; VIROLOGY; VIRUS LOAD;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1;

AMINO ACID SUBSTITUTION; COHORT STUDIES; DRUG RESISTANCE, VIRAL; HIV INFECTIONS; HIV PROTEASE INHIBITORS; HIV-1; ITALY; MICROBIAL SENSITIVITY TESTS; MOLECULAR SEQUENCE DATA; REVERSE TRANSCRIPTASE INHIBITORS; VIRAL LOAD;

EID: 19044364264     PISSN: 14712180     EISSN: 14712180     Source Type: Journal    
DOI: 10.1186/1471-2180-1-30     Document Type: Article

References (28)

1. Hirsch MS, Brun-Vezinet F, D'Aquila RT, Hammer SM, Johnson VA, Kuritzkes DR, Loveday C, Mellors JW, Clotet B, Conway B, Demeter LM, Vella S, Jacobsen DM, Richman DD: Antiretroviral drug resistance testing in adult HIV-1 infection: recommendations of an International AIDS Society-USA Panel. JAMA 2000, 283:2417-2426
2. Young B, Johnson S, Bahktiari M, et al: Resistance mutations in protease and reverse transcriptase genes of human immunodeficiency virus type 1 isolates from patients with combination antiretroviral therapy failure. J Infect Dis 1998, 178:1497-501
3. Boden D, Hurley A, Zhang L, et al: HIV-1 drug resistance in newly infected individuals. JAMA 1999, 282:1135-41
4. Ribeiro RM, Bonhoeffer S, Nowak MA: The frequency of resistant mutant virus before antiviral therapy. AIDS 1998, 12:461-465
5. Birk M, Sonnerborg A: Variations in HIV-1 pol gene associated with reduced sensitivity to antiretroviral drugs in treatment-naive patients. AIDS 1998, 12:2369-2375
6. Re MC, Monari P, Borderi M, Tadolini M, Verucchi G, Vitone F, Spinosa S, La Placa M: Presence of genotypic resistance to antiretroviral drugs in a cohort of therapy naive HIV-1 infected Italian patients. J Acquir Immune Defic Syndr 2001, 27:315-316
7. Hirsch MS, Conway B, D'Aquila RT, Johnson JA, Brun-Vezinet F, Clotet B, Demeter LM, Hammer SM, Jacobsen DM, Kuritzkes DR, Loveday C, Mellors JW, Vella S, Richman DD: Antiretroviral drug resistance testing in adults with HIV infection: implications for clinical management. International AIDS Society-USA Panel. JAMA 1998, 279:1984-1991 [http://hivinsite.ucsf.edu/In-Site.jsp?doc=2098. 474c)]
8. D'Aquila R: Incorporating antiretroviral resistance testing into clinical practice. A new standard of care in the management of HIV disease. [http://www.visgen.com/clinical_Science/ The Lybrary/HIV/ Trugene_Monograph_6191pdfA]
9. Pillay D, Cane PA, Shirley J, Porter K: Detection of drug resisitance associated mutations in HIV primary infection within the UK. AIDS 2000, 14:906-908
10. Yerly, Rakik A, Kinloch-de-Loes S, Erb P, Vernazza P, Hirschel B, Perrin L: Prevalence of transmission of zidovudine-resistant viruses in Switzerland. l'Etude suisse de cohorte VIH]. Schweiz Med Wochenschr 1996, 126:1845-1848
11. Imrie A, Beveridge A, Genn W, Vizzard J, Cooper DA: Transmission of human immunodeficiency virus type 1 resistant to ne-virapine and zidovudine. Sydney Primary HIV Infection Study Group. J Infect Dis 1997, 175:1502-1506
12. Carpenter CC, Fischl MA, Hammer SM, Hirsch MS, Jacobsen DM, Katzenstein DA, Montaner JS, Richman DD, Saag MS, Schooley RT, Thompson MA, Vella S, Yeni PG, Volberding PA: Antiretroviral therapy for HIV infection in 1998: updated recommendations of the International AIDS Society-USA Panel. JAMA 1998, 280:78-86
13. Conway B, Montessori V, Rouleau D, Montaner JS, MV'Shaughnessy O, Fransen S, Shillington A, Weislow O, Mayers DL: Primary lamivudine resistance in acute/early human immunodeficiency virus infection. Clin Infect Dis 1999, 28:910-911
14. Hecht FM, Grant RM, Petropoulos CJ, Dillon B, Chesney MA, Tian H, Hellmann NS, Bandrapalli NI, Digilio L, Branson B, Kahn JO: Sexual transmission of an HIV-1 variant resistant to multiple reverse-transcriptase and protease inhibitors. N Engl J Med 1998, 339:341-343
15. Pillay, Taylor S, Richman DD: Incidence and impact of resistance against approved antiretroviral drugs. Rev Med Virol 2000, 10:231-253
16. Hanna GJ, D'Aquila RT: Clinical Use of Genotypic and Phenotypic Drug Resistance Testing to Monitor Antiretroviral Chemotherapy. Clinical Infectious Diseases 2001, 32:774-782
17. Tamalet C, Pasquier C, Yahi N, Colson P, Poizot-Martin I, Lepeu G, Gallais H, Massip P, Puel J, Izopet J: Prevalence of drug resistant mutants and virological response to combination therapy in patients with primary HIV-1 infection. J Med Virol 2000, 61:181-186
18. Wain-Hobson S, Sonigo P, Danos O, Cole S, Alizon M: Nucleotide sequence of the AIDS virus, LAV. Cell 1985, 40:9-17
19. Bacheler LT, Anton ED, Kudish P, Baker D, Bunville J, Krakowski K, Bolling L, Aujay M, Wang XV, Ellis D, Becker MF, Lasut AL, George HJ, Spalding DR, Hollis G, Abremski K: Human immunodeficiency virus type 1 mutations selected in patients failing efavirenz combination therapy. Antimicrob Agents Chemother 2000, 44:2475-2484
20. Gallego O, Briones C, Corral A, Soriano V: Prevalence of novel lamivudine-resistant genotypes (E44D/A, V118I) in naive and pretreated HIV-infected individuals. J Acquir Immune Defic Syndr 2000, 5:95-96
21. Stuyver L, Wyseur A, Rombout A, Louwagie J, Scarcez T, Verhofstede C, Rimland D, Schinazi RF, Rossau R: Line probe assay for rapid detection of drug-selected mutations in the human immunodeficiency virus type 1 reverse transcriptase gene. Antimicrob Agents Chemother 1997, 41:284-291
22. Servais J, Lambert C, Fontaine E, Plesseria JM, Robert I, Arendt V, Staub T, Schneider F, Hemmer R, Burtonboy C, Schmit JC: Comparison of DNA sequencing and a line probe assay for detection of human immunodeficiency virus type 1 drug resistance mutations in patients failing highly active antiretroviral therapy. J Clin Microbiol 2001, 39:454-459
23. Descamps D, Calvez V, Collin G, Cecille A, Apetrei C, Damond F, Katlama C, Matheron S, Huraux JM, Brun-Vezinet F: Line probe assay for detection of human immunodeficiency virus type 1 mutations conferring resistance to nucleoside inhibitors of reverse transcriptase: comparison with sequence analysis. J Clin Microbiol 1998, 36:2143-2145
24. Wilson JW, Bean P, Robins T, Graziano F, Persing DH: Comparative evaluation of three human immunodeficiency virus genotyping systems: the HIV-GenotypR method, the HIV PRT GeneChip assay, and the HIV-1 RT line probe assay. J Clin Microbiol 2000, 38:3022-3028
25. Puchhammer-Stockl E, Schmied B, Mandl CW, Vetter N, Heinz FX: Comparison of line probe assay (LIPA) and sequence analysis for detection of HIV-1 drug resistance. J Med Virol 1999, 57:283-289
26. Koch N, Yahi N, Colson P, Fantini J, Tamalet C: Genetic polymorphism near HIV-1 reverse transcriptase resistance-associated codons is a major obstacle for the line probe assay as an alternative method to sequence analysis. J Virol Meth 1999, 80:25-31
27. Perez-Alvarez L, Villahermosa ML, Cuevas MT, Delgado MT, Manjon N, Vazquez de Parga E, Medrano L, Contreras G, Thomson MM, Colomo C, Taboada JA, Najera R: Single- and multidrug resistance mutations to reverse transcriptase and protease inhibitors: human immunodeficiency virus type 1-infected patients from two geographical areas in Spain. Spanish Groups for Antiretro viral Resistance Studies. J Hum Virol 2000, 3:150-156
28. Kijak GH, Carobene MG, Salomon H H: A highly prevalent polymorphism at codon 72 of HIV-1 reverse transcriptase in Argentina prevents hybridization reaction at codon 74 in the LIPA genotyping test. J Virol Meth 2001, 94:87-95